{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:24:20Z","timestamp":1793967860390,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.100868","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:13:39Z","timestamp":1770675219000},"page":"100868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination of serum TBL1XR1, MFAP5, and PSA as diagnostic biomarkers for prostate cancer"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9850-5326","authenticated-orcid":false,"given":"Xianxian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0552-4387","authenticated-orcid":false,"given":"Xiuping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4185-8556","authenticated-orcid":false,"given":"Jiejun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clinsp.2026.100868_bib0001","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/biom13121715","article-title":"Caspase-linked programmed cell death in prostate cancer: from apoptosis, necroptosis, and pyroptosis to PANoptosis","volume":"13","author":"Zhu","year":"2023","journal-title":"Biomolecules"},{"issue":"16","key":"10.1016\/j.clinsp.2026.100868_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612797","article-title":"Prostate cancer: genetics, epigenetics and the need for immunological biomarkers","volume":"24","author":"Rafikova","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100868_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000519861","article-title":"Metastatic prostate cancer: treatment options","volume":"100","author":"Achard","year":"2022","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100868_bib0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-021-03618-4","article-title":"Advanced prostate cancer","volume":"39","author":"Hupe","year":"2021","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100868_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/cancers16010165","article-title":"Clinical biofluid assays for prostate cancer","volume":"16","author":"Borbiev","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.clinsp.2026.100868_bib0006","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","article-title":"Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer","volume":"344","author":"Barry","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100868_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/and.13980","article-title":"Deficiency of TBL1XR1 causes asthenozoospermia","volume":"53","author":"Zhou","year":"2021","journal-title":"Andrologia"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100868_bib0008","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/emboj\/cdg120","article-title":"Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1","volume":"22","author":"Yoon","year":"2003","journal-title":"EMBO J"},{"issue":"3-4","key":"10.1016\/j.clinsp.2026.100868_bib0009","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41417-019-0111-0","article-title":"TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer","volume":"27","author":"Zhang","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.clinsp.2026.100868_bib0010","article-title":"Correlations between TBL1XR1 and recurrence of colorectal cancer","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100868_bib0011","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1620\/tjem.241.239","article-title":"Over-expression of TBL1XR1 indicates poor prognosis of serous epithelial ovarian cancer","volume":"241","author":"Ma","year":"2017","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100868_bib0012","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s42003-020-01175-x","article-title":"Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype","volume":"3","author":"Simpson","year":"2020","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.clinsp.2026.100868_bib0013","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/kjm2.12758","article-title":"miR-199a\/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1","volume":"39","author":"Hu","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.clinsp.2026.100868_bib0014","article-title":"3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clinsp.2026.100868_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1309687","article-title":"Two decades of a protooncogene TBL1XR1: from a transcription modulator to cancer therapeutic target","volume":"14","author":"Du","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100868_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jcp.29893","article-title":"Molecular structure and function of microfibrillar-associated proteins in skeletal and metabolic disorders and cancers","volume":"236","author":"Zhu","year":"2021","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.clinsp.2026.100868_bib0017","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1038\/nutd.2011.10","article-title":"Microfibrillar-associated protein 5 is linked with markers of obesity-related extracellular matrix remodeling and inflammation","volume":"1","author":"Vaittinen","year":"2011","journal-title":"Nutr Diabetes"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100868_bib0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2018.03.007","article-title":"MFAP5 promotes tumor progression and bone metastasis by regulating ERK\/MMP signaling pathways in breast cancer","volume":"498","author":"Wu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100868_bib0019","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.7150\/jca.38217","article-title":"Hypoxia-induced MFAP5 promotes tumor migration and invasion via AKT pathway in head and neck squamous cell carcinoma","volume":"11","author":"Xu","year":"2020","journal-title":"J Cancer"},{"issue":"25","key":"10.1016\/j.clinsp.2026.100868_bib0020","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/s41388-023-02711-9","article-title":"Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix","volume":"42","author":"Duan","year":"2023","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100868_bib0021","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00428-020-02925-2","article-title":"Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility","volume":"478","author":"Zhao","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clinsp.2026.100868_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1084192","article-title":"DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma","volume":"12","author":"Ke","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100868_bib0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/biomedicines8060173","article-title":"The percentage of free PSA and urinary markers distinguish prostate cancer from benign hyperplasia and contribute to a more accurate indication for prostate biopsy","volume":"8","author":"Huskova","year":"2020","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100868_bib0024","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/aja202182","article-title":"Clinical application of free\/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml(-1) in Western China","volume":"24","author":"Gao","year":"2022","journal-title":"Asian J Androl"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100868_bib0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","article-title":"Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future","volume":"19","author":"Van Poppel","year":"2022","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100868_bib0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"27","key":"10.1016\/j.clinsp.2026.100868_bib0027","doi-asserted-by":"crossref","first-page":"41110","DOI":"10.18632\/oncotarget.9002","article-title":"SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"issue":"25","key":"10.1016\/j.clinsp.2026.100868_bib0028","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3748\/wjg.v26.i25.3586","article-title":"TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K\/AKT pathway in pancreatic ductal adenocarcinoma","volume":"26","author":"Gu","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"21","key":"10.1016\/j.clinsp.2026.100868_bib0029","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1158\/1078-0432.CCR-19-0187","article-title":"Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer","volume":"25","author":"Yeung","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinsp.2026.100868_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1084192","article-title":"DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma","volume":"12","author":"Ke","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100868_bib0031","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13046-019-1477-4","article-title":"MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway","volume":"38","author":"Li","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100868_bib0032","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00428-020-02925-2","article-title":"Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility","volume":"478","author":"Zhao","year":"2021","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100868_bib0033","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2023.010101","article-title":"On determining the sensitivity and specificity of a new diagnostic test through comparing its results against a non-gold-standard test","volume":"33","author":"Habibzadeh","year":"2023","journal-title":"Biochem Med (Zagreb)"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:24:33Z","timestamp":1793964273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"alternative-id":["S1807593226000098"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100868","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of serum TBL1XR1, MFAP5, and PSA as diagnostic biomarkers for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100868"}}